ArticleThe Journal of clinical investigation2026

PARP inhibitors restore NK cell function via secretory crosstalk with tumor cells in prostate cancer.

Zheng Chao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.